| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 310 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 303 |
| 2 | TACROLIMUS OINTMENT 0.1% | 303 |
| 3 | MYCOPHENOLATE MOFETIL | 242 |
| 4 | PREDNISONE | 196 |
| 5 | MYCOPHENOLIC ACID | 50 |
| 6 | METHYLPREDNISOLONE | 41 |
| 7 | MYCOPHENILIC ACID | 41 |
| 8 | PREDNISOLONE | 32 |
| 9 | PREDNISOLONE ORAL | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CIDOFOVIR ANHYDROUS | 9 | 0.0062 |
| 1 | TACROLIMUS OINTMENT 0.1% | 303 | 0.0024 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 303 | 0.0024 |
| 3 | TACROLIMUS | 310 | 0.0019 |
| 4 | MYCOPHENILIC ACID | 41 | 0.0019 |
| 5 | MYCOPHENOLATE MOFETIL | 242 | 0.0017 |
| 6 | MARAVIROC | 4 | 0.0017 |
| 7 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 13 | 0.0016 |
| 8 | MYCOPHENOLIC ACID | 50 | 0.0015 |
| 9 | SIROLIMUS | 19 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 41 | 0.0019 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 4 | 0.0017 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 17 | 0.0008 |
| 4 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 6 | 0.0003 |
| 6 | Purine Antimetabolite [EPC] | 30 | 0.0003 |
| 7 | Hedgehog Pathway Inhibitor [EPC] | 2 | 0.0002 |
| 8 | Corticosteroid [EPC] | 256 | 0.0002 |
| 9 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |